TownSquare Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-111,229
Closed -$2.55M 1403
2025
Q1
$2.55M Buy
111,229
+85,419
+331% +$2.06M 0.03% 542
2024
Q4
$654K Sell
25,810
-9,078
-26% -$230K 0.01% 913
2024
Q3
$870K Sell
34,888
-17,791
-34% -$527K 0.01% 757
2024
Q2
$1.56M Buy
52,679
+373
+0.7% +$10.3K 0.02% 567
2024
Q1
$1.58M Buy
52,306
+2,440
+5% +$67.7K 0.02% 529
2023
Q4
$1.43M Sell
49,866
-6,976
-12% -$205K 0.02% 505
2023
Q3
$2.11M Sell
56,842
-2,966
-5% -$113K 0.04% 385
2023
Q2
$2.33M Buy
59,808
+5,912
+11% +$232K 0.04% 354
2023
Q1
$1.97M Buy
53,896
+2,206
+4% +$69.6K 0.04% 327
2022
Q4
$1.59M Buy
+51,690
New +$1.6M 0.04% 354

Other funds holding RTO

TownSquare Capital's RTO Position: Q2 2025 in Review

TownSquare Capital sold out of Rentokil (RTO) in Q2 2025, closing a stake of 111,229 shares — an estimated $2.55M sold.

TownSquare Capital first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $2.55M in Q1 2025. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • TownSquare Capital reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 111,229 Rentokil shares in Q2 2025, an estimated $2.55M.
  • TownSquare Capital first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • TownSquare Capital's Rentokil position peaked at $2.55M in Q1 2025.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.